Calcium, Phosphate and Bone Flashcards

1
Q

Homeostasis and Functions of Calcium

A

1000 mg/day intake (25 mmol/day)

  • bone as the main depot in the body (35000 mmol - 99% body Ca; bone remodelling)
  • calcium carbonate supplement (40% elemental Ca)

Functions:

  • strength of skeleton
  • coagulation cascade
  • maintain cellular membrane potential
  • cardiac contractility and rhythm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Calcium in circulation (1% body Ca)

A

*Ionised free Ca is the biologically active form (50% plasma Ca)

Ca bound to plasma albumin (40%)

Complexed with anions (10%)

Total plasma Ca RR: 2.1-2.55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Albumin-adjusted Ca

A

Total plasma Ca measured includes free ionised Ca and albumin-bound Ca

  • cheaper to measure
  • changes in albumin will affect Ca measurement

Adjusted Ca = measured [Ca] + [(40-albumin in g/L) x 0.025]

–> inaccurate for extremes (<25 g/L or>50g/L) – need ionised Ca measurement

Ionised Ca

  • specialised collection bottle, freeze after collection
  • useful in massive derangement of albumin/ neonates with high AFP (same binding as albumin - less blood required, faster measurement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Manifestations of hyperCa and hypoCa

A

HyperCa

  • Stones, Abdominal Groans, Painful bones and psychic moans
  • nephrocalcinosis
  • nausea, vomiting, ileus, peptic ulcer (increased gastrin), pancreatitis (deposition of Ca in duct, Ca +ve trypsinogen)
  • brown tumour (rapid bone loss, replace by haemorrhage), osteitis fibrosa cystica
  • lethargy, depression
  • muscle weakness, bradycardia, polyuria, polydipsia

HypoCa

  • enhanced neuromuscular excitability –> +ve chvostek’s sign, trousseau’s sign, tetany, seizures, cramps
  • perioral numbness, paraesthesia
  • arrhythmia
  • irritability
  • basal ganglia calcification, sub capsular infarcts (chronic Ca deposition)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Regulation of ionised Ca

A
  1. PTH
    - increase Ca and decrease PO4
    - **Bone: increase resorption (osteoblast–>osteoclast)
    - Kidney: increase reabsorption of Ca (DT, TAL), decrease renal reabsorption of PO4 (PCT), increase 1-alpha hydroxylase (for calcitriol production)
    - Intestines: increased 1-alpha hydroxylase leads to increase Ca and PO4 reabsorption
  2. Vitamin D3/ Calcitriol/ 1,25 dihydroxycholecalciferol (slower response)
    - increase Ca and PO4
    - Bone: potentiate PTH action of resorption (but suppressed at high PTH and has neg feedback on PTH)
    - Intestines: increase Ca and PO4 absorption
  3. Calcitonin
    - decrease Ca and PO4
    - Bone: decrease osteoclast activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HyperCa: causes

A

Common:

  1. Parathyroid disease
    - hyperPTH: primary e.g. adenoma, hyperplasia or tertiary (autonomous PTH secretion due to chronic hypoCa and stimulation of parathyroid glands)
    - MEN1 and MEN2a
  2. Malignant disease (humoral hyperCa of malignancy)
    - lytic lesions of bone e.g. breast CA metastasis
    - malignant cells release other mediators e.g. osteoclast activating factors in myeloma
    - PTHrP release e.g. SQCC of lung, HCC, head and neck CA, oesophagus
    - ectopic production of calcitriol by lymphomas

Uncommon:

  • endogenous calcitriol e.g. sarcoidosis, TB
  • excessive absorption of Ca e.g. vitamin D overdose, milk-alkali syndrome
  • thiazide diuretics
  • familial hypocalciuric hyperCa (CaSR gene mutation; AD with full penetrance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Primary HyperPTH vs Hypercalcemia of Malignancy: Ca levels, onset, renal stone formation, PTH levels, PO4 levels

A

Primary HyperPTH

  • Ca <3.0 mmol/L
  • chronic, insidious onset
  • renal stones common (takes time to form)
  • *plasma PTH high or inappropriately normal
  • plasma PO4 usually low

Malignancy

  • Ca >3.0 mmol/L (no physiological feedback mech)
  • acute onset (months)
  • renal stones rare
  • *plasma PTH suppressed

(both have high Ca, low PO4 in HHM, high ALP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Approach to HyperCa

A
  1. Confirm hyperCa (albumin-adjustment)
  2. PTH assessment
    - -> high/ inappropriately normal = hyperPTH (normal/ high 24 hr urine Ca; primary or tertiary depending on RFT) or familial hypocalciuric hyperCa (low 24 hr urine Ca)
    - -> suppressed = malignancy, TB, others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DDx patterns for hyperCa

A

Low PO4

  • primary hyperPTH
  • PTHrP releasing malignancy

High PO4

  • malignancy (primary or secondary deposits)
  • post-dialysis in renal failure, tertiary hyperPTH
  • TB (overproduction of Vit D)
  • Vit D overdose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DDx of hypoCa

A

Exclude artefact from contamination of tubes with EDTA or oxalate

High PO4

  • hypoparathyroidism e.g. thyroidectomy, congenital absence of glands
  • secondary hyperparathyroidism i.e. renal failure –> PO4 retention in CKD and failure of vitamin D activation causes hypoCa which stimulates PTH release (can lead to renal osteodystrophy)
  • pseudohypoparathyroidism (tissue resistance to PTH; PTH very high)
  • hypoMg – required for PTH secretion and action

Low PO4

  • vitamin D deficiency e.g. little sun exposure, malnutrition, fat malabsorption –> *high ALP and low 25-OH-Vitamin D (storage form)
  • acute pancreatitis –> Ca and PO4 sequestration in abdomen leading to saponification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Beware! Vitamin D deficiency will never cause high Ca!

A

Primary hyperPTH can cause low Vitamin D (suppressed at high PTH) but will have high Ca –> not vit D deficiency!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mg and causes of deficiency

A

Cofactor required for PTH secretion and action (and also affects K excretion)

Reduced intake
- alcoholism, malnutrition, total parenteral nutrition

Abnormal loss

  • renal: renal disease e.g. RTA, Barter/Gitelman, chronic pyelonephritis
  • extra-renal: primary or secondary hyperaldosteronism/ diuresis; primary or tertiary hyperPTH

=> insensitive to vitamin D or Ca supplement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Metabolic Bone Diseases

A

Most with normal Ca and PO4 except rickets and osteomalacia

definition, aetiology, bone turnover markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Osteoporosis

A

Common disorder affecting 1/4 older women

  • LOW BONE MASS and susceptibility to vertebral, forearm and hip fractures
  • structure and composition of bone is normal
  • -2.5 SD from peak bone mass (osteopenia if -1.5 SD)

Ca, PO4, ALP, PTH all normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Osteomalacia and Rickets

A

Vitamin D deficiency or disturbed metabolism of vitamin D

  • SOFT BONES (DEFECTIVE MINERALISATION, abrnomal composition)
  • rickets in children
  • osteomalacia in adults

Diffuse bone pain, tenderness, muscle weakness
XR: decreased density and *thinning of bone cortex
Deformed bones in advanced disease e.g. concavity of vertebral bodies, bowed legs
Fissures/ Cracks (looser’s zones)

Low Ca, PO4, 25-OH-Vit D
High ALP, PTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Osteopetrosis

A

Marble bone disease (very rare inherited)
- bones harden and become denser

Ca, PO4, PTH normal
High ALP

17
Q

Paget’s disease of bone

A

Dysregulated bone remodelling leading to deformity and abnormal architecture

Dx:

  • characteristic XR appearance
  • high ALP with normal Ca and PO4 in elderly
18
Q

Osteitis Fibrosa Cystica

A

Long term effect of untreated hyperPTH
- prone to pathological fractures

Same lab picture as hyperPTH (High Ca, low PO4, High ALP and PTH)

19
Q

Renal osteodystrophy

A

Osteomalacia + secondary hyperPTH
- poor RFT

High/Low Ca
High PO4, ALP and PTH

20
Q

Treatment of acute hyperCa

A

Dx and treat underlying cause

Correct dehydration (ensure sufficient renal filtration and Ca excretion)

Bisphosphonates (inhibit osteoclast activities and improve osteoblast survival)

Further Mx: chemo in malignancy, steroids in sarcoidosis, calcitonin also inhibit osteoclasts

Biologics:
- denosumab (Ab against human RANKL) – treat osteoporosis and acute severe hyperCa